fibromyalgia

Synthetics Biologics

Synthetic Biologics Launches Free Investor Relations Mobile Application

Synthetic Biologics Inc. (NYSE Amex: SYN) Thursday announced the release of its investor relations mobile iPhone App, called the “SYN IR” App, now available for free at the Apple App Store on the iPhone or iPad or at http://bit.ly/I9xDpW.

WWJ Newsradio 950–04/26/2012

adeona2

Adeona Names New Managers, Eyes Name Change

Adeona Pharmaceuticals Inc. has swapped bosses as it continues testing new drugs for multiple sclerosis, fibromyalgia and Lou Gehrig’s disease. It’s also considering a new business focus and a name change.

WWJ Newsradio 950–02/06/2012

adeona2

Adeona Loss Grows, But Milestones Reached

Ann Arbor-based Adeona Pharmaceuticals Inc. (AMEX: AEN), a developer of medicines for serious central nervous system diseases, Monday reported its second quarter financial results for the period ended June 30, as well as updates since the beginning of the second quarter.

WWJ Newsradio 950–08/15/2011

Wayne State Prof Gets $3.4M From NIH For Fibromyalgia Research

A Wayne State University researcher is investigating whether therapy that focuses on education, symptom management or confronting avoided emotional experiences is the best approach for fibromyalgia, a common and disabling pain condition. Mark A. Lumley, […]

11/07/2010

Follow

Get every new post delivered to your Inbox.

Join 1,995 other followers